Zurich Cantonal Bank’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
Other funds holding TXMD
CWG
RCMNY
Zurich Cantonal Bank's TXMD Position: Q4 2021 in Review
Zurich Cantonal Bank sold out of TherapeuticsMD (TXMD) in Q4 2021, closing a stake of 279 shares — an estimated $10K sold.
Zurich Cantonal Bank first reported a position in TXMD in Q2 2015 and held it in 26 quarters. The position peaked at $92K in Q3 2018. 131 funds tracked by Wall St. Rank hold TXMD as of Q4 2021.
- Zurich Cantonal Bank reported no remaining TherapeuticsMD position as of Q4 2021 after selling out during the quarter.
- Zurich Cantonal Bank sold 279 TherapeuticsMD shares in Q4 2021, an estimated $10K.
- Zurich Cantonal Bank first reported a position in TherapeuticsMD in Q2 2015 and held it in 26 quarters.
- Zurich Cantonal Bank's TherapeuticsMD position peaked at $92K in Q3 2018.
- 131 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2021.
Based on Zurich Cantonal Bank's 13F filing for Q4 2021, filed 1 Feb 2022.